Uploaded October 2026 | Updated November 2026, 4 hours ago
Jane Salmon, MD, Professor of Medicine at Weill Cornell Medical College, discusses antiphospholipid syndrome (APS), its impact on pregnancy, and emerging research into Cimzia (certolizumab pegol) as a potential approach to preventing serious pregnancy complications.
View the full interview at checkrare.com/fda-grants-breakthrough-therapy-designation-to-cimzia-for-pregnancy-complications-in-antiphospholipid-syndrome
Jane Salmon, MD, Professor of Medicine at Weill Cornell Medical College, discusses antiphospholipid syndrome (APS), its impact on pregnancy, and emerging research into Cimzia (certolizumab pegol) as a potential approach to preventing serious pregnancy complications.
View the full interview at checkrare.com/fda-grants-breakthrough-therapy-designation-to-cimzia-for-pregnancy-complications-in-antiphospholipid-syndrome










